Substance and claimed effects

The Mediterranean dietary pattern is a whole-diet composition modeled on the traditional eating habits of olive-growing regions of southern Europe (Crete, southern Italy, coastal Spain, Greece) circa mid-20th century. Its operational defining features, codified across adherence scoring instruments (Trichopoulou's MedDiet Score and the PREDIMED 14-item screener), are: extra-virgin olive oil (EVOO) as the primary added fat; high intake of vegetables, legumes, fruits, whole grains, and nuts; regular fish and seafood (≥2 servings/week); moderate dairy (preferentially fermented — yogurt, aged cheese); low-to-moderate poultry and eggs; minimal red and processed meat; minimal refined grains, added sugars, and ultra-processed foods; optional moderate wine with meals. The pattern is plant-forward without being vegetarian, fat-permissive (≥35–40% of energy from fat in PREDIMED) but heavily monounsaturated. Claimed consequences span cardiovascular endpoints (MI, stroke, CV mortality), blood pressure, blood lipids (LDL particle number, HDL, triglycerides), insulin resistance and type-2 diabetes incidence, cognitive decline and Alzheimer's risk, mood and depression, certain cancers (especially breast), inflammatory markers (hs-CRP, IL-6), all-cause mortality, body composition, and gut microbiome diversity. This entry covers the full set; the dimension scoring is holistic.

Evidence by addressing question

mechanism

Multiple converging mechanisms, none singly sufficient. Monounsaturated fat shift: replacing saturated fat with EVOO's oleic acid (≈70% of EVOO fatty acids) lowers LDL-C without lowering HDL, an effect baked into AHA dietary guidance Lichtenstein et al. 2021. Polyphenols: EVOO contains oleocanthal, a natural COX-1/COX-2 inhibitor with ibuprofen-like anti-inflammatory potency at culinary doses — 50 g of unfiltered EVOO ≈ 10% of an adult ibuprofen dose for COX inhibition Beauchamp et al. 2005. Hydroxytyrosol, oleuropein, and lignans from olives plus flavonoids from vegetables and red wine extend the anti-inflammatory profile. Omega-3 PUFAs from fish (EPA, DHA) and walnuts (ALA) lower triglycerides, raise membrane fluidity, reduce platelet aggregation, and feed resolvin pathways that actively terminate inflammation. Fiber load from legumes, whole grains, vegetables, and fruits (≥30 g/day in adherent participants) feeds short-chain-fatty-acid-producing gut bacteria; Mediterranean adherence shifts the microbiome toward higher Faecalibacterium prausnitzii and Roseburia abundance and lowers Firmicutes:Bacteroidetes ratio Garcia-Mantrane et al. 2018. Nitrate-rich vegetables (leafy greens, beets) convert via the enterosalivary cycle to NO, lowering systolic BP by ~3–5 mmHg. Glycemic profile: legume + whole-grain dominance flattens postprandial glucose, lowering integrated insulin secretion across the day and improving HOMA-IR within 8–12 weeks. Pattern synergy: meta-analyses adjusting for individual components show the whole-pattern effect exceeds the sum of single-nutrient effects, consistent with synergy among polyphenols, fiber, MUFAs, and omega-3s rather than a single bioactive driver Dinu et al. 2018.

evidence

This is one of the most-tested dietary patterns in the literature, with primary-prevention and secondary-prevention RCTs and large prospective cohorts converging on the same direction.

PREDIMED (republished). Multicenter Spanish RCT, n=7,447, high cardiovascular risk participants (type-2 diabetes or ≥3 risk factors), median follow-up 4.8 years. Three arms: Mediterranean diet supplemented with EVOO (1 L/week free), Mediterranean diet supplemented with mixed nuts (30 g/day free), or low-fat control diet. Primary composite endpoint (MI, stroke, CV death): hazard ratios 0.69 (95% CI 0.53–0.91) for EVOO arm and 0.72 (0.54–0.95) for nuts arm versus control — ~30% relative risk reduction Estruch et al. 2018. Stroke was the most strongly affected component endpoint. The 2013 publication was retracted in 2018 due to randomization deviations at a minority of sites (some cluster-randomized in error); the republished per-protocol analysis used multilevel mixed-effects modelling and the conclusions held in magnitude and direction.

Lyon Diet Heart Study. Secondary prevention RCT, n=605 post-MI patients in Lyon, France. ALA-enriched Mediterranean-style diet (canola-margarine substitute provided to enrich α-linolenic acid) vs prudent post-infarct control. Trial terminated early at 27 months for benefit; final 46-month report showed ~50–70% relative reduction in recurrent CV events (composite of cardiac death and non-fatal MI: RR 0.28, 95% CI 0.15–0.53) de Lorgeril et al. 1999. Small but the effect size is dramatic; this trial put the pattern on cardiologists' radar before PREDIMED scaled the evidence.

CORDIOPREV. Spanish RCT, n=1,002 patients with established coronary heart disease, randomised to Mediterranean diet or a low-fat diet, followed median 7 years. Composite of MI, revascularisation, ischemic stroke, peripheral artery disease, CV death: HR 0.74 (95% CI 0.58–0.96) in Mediterranean arm — ~26% relative reduction in secondary prevention Delgado-Lista et al. 2022. Independent replication of the Lyon and PREDIMED signal in a longer-follow-up secondary-prevention setting.

Diabetes incidence. PREDIMED diabetes-free subgroup (n=3,541): Mediterranean+EVOO and Mediterranean+nuts vs low-fat control, type-2 diabetes incidence over median 4.1 years showed HRs 0.60 and 0.82 respectively; pooled MedDiet arms HR 0.70 (0.54–0.92) — ~30% relative reduction without prescribed caloric restriction or weight loss Salas-Salvadó et al. 2014.

Cognition. PREDIMED-NAVARRA cognitive substudy (n=522): MMSE and Clock Drawing Test improved in Mediterranean+EVOO and Mediterranean+nuts arms vs control after 6.5 years Martínez-Lapiscina et al. 2013. The MIND diet (Mediterranean-DASH hybrid emphasising berries and leafy greens) in the Memory and Aging Project (n=923, mean follow-up 4.5 years) showed HR 0.47 (95% CI 0.26–0.76) for incident Alzheimer's in the highest-adherence tertile versus the lowest Morris et al. 2015.

Depression and mood. SMILES RCT (n=67, modified Mediterranean diet "ModiMedDiet" + social support vs social-support-only control, 12 weeks): 32.3% remission in diet arm vs 8.0% in control (NNT ≈ 4) in moderate-to-severe major depression Jacka et al. 2017. Small but the magnitude is on the order of an SSRI's effect. HELFIMED (n=152) Mediterranean diet + fish oil vs befriending control: significant depression-score improvement at 3 and 6 months, sustained through 6-month follow-up Parletta et al. 2019. Lassale meta-analysis of 41 studies: highest vs lowest Mediterranean adherence quintile pooled OR for depression 0.67 (95% CI 0.55–0.82) Lassale et al. 2019.

Cancer. Schwingshackl umbrella meta-analysis of 83 studies: pooled RR for overall cancer mortality 0.86 (0.81–0.91) at highest vs lowest adherence; breast cancer RR 0.94 (0.90–0.99) Schwingshackl et al. 2017. PREDIMED breast-cancer substudy (women only, n=4,282): Mediterranean+EVOO showed HR 0.32 (95% CI 0.13–0.79) vs low-fat control for invasive breast cancer (62 events total) Toledo et al. 2015 — small absolute numbers but the relative effect is large.

All-cause mortality. Trichopoulou Greek EPIC cohort (n=22,043): 2-point increase on the 9-point MedDiet Score associated with HR 0.75 (0.64–0.87) for all-cause mortality Trichopoulou et al. 2003. Sofi meta-analysis pooling 18 prospective cohorts (n≈4.5M): 2-point adherence increase associated with RR 0.92 (0.90–0.94) all-cause mortality, 0.90 (0.87–0.92) CV mortality, 0.87 (0.79–0.97) Parkinson's, 0.87 (0.81–0.94) Alzheimer's Sofi et al. 2014. Recent Nurses' Health Study analysis (n=25,315 women, 25-year follow-up): highest vs lowest MedDiet adherence HR 0.77 (0.74–0.80) for all-cause mortality Ghosn et al. 2024. Dinu umbrella review covering 13 meta-analyses concluded Mediterranean adherence reduces all-cause mortality, CV events, cancer, neurodegenerative disease, and type-2 diabetes incidence with consistent directionality across observational and trial evidence Dinu et al. 2018.

Body composition. PREDIMED prespecified weight outcomes (n=7,447): despite no calorie restriction and ~40% fat intake, Mediterranean+EVOO arm lost 0.43 kg more body weight and 0.42 cm more waist circumference than control over 5 years; Mediterranean+nuts +0.08 kg vs control but −0.94 cm waist Estruch et al. 2019. The pattern is weight-neutral-to-favorable without active caloric restriction — meaningful because most diet interventions fail on long-term weight maintenance.

practice

Mediterranean diet is endorsed as a first-line dietary pattern by the 2019 ACC/AHA Primary Prevention Guideline (Class I, Level B-R recommendation for adults to consume a diet emphasizing vegetables, fruits, legumes, nuts, whole grains, and fish) Arnett et al. 2019 and the 2021 AHA Scientific Statement on Dietary Guidance to Improve Cardiovascular Health Lichtenstein et al. 2021. The 2020–2025 US Dietary Guidelines list the "Healthy Mediterranean-Style Dietary Pattern" as one of three reference patterns. ESC (European Society of Cardiology) prevention guidelines name it explicitly. The American Diabetes Association includes Mediterranean diet among recommended eating patterns for T2D management. WHO recognises it as a Representative List intangible cultural heritage element (UNESCO 2013).

protocol

Operationally a 14-point PREDIMED-style adherence checklist defines daily/weekly targets: EVOO as the principal cooking fat; ≥4 tablespoons EVOO per day (PREDIMED participants in the EVOO arm averaged ~50 g/day of supplemented EVOO on top of background use); ≥2 servings vegetables/day (one raw or in salad); ≥3 servings fruit/day; <1 serving red or processed meat per day, preferably weekly; <1 serving butter/margarine/cream per day; <1 sugar-sweetened beverage per day; ≥7 servings/week red wine (this component is widely deprecated outside Spain on ethical grounds — see misconceptions); ≥3 servings/week legumes; ≥3 servings/week fish or seafood; <3 servings/week commercial sweets; ≥3 servings/week nuts; preferring poultry over red meat; ≥2 vegetable-based sofrito-style preparations per week. The pattern is composition-defined, not calorie-defined; PREDIMED prescribed no caloric restriction and no exercise. Adaptation outside Mediterranean cultures keeps the composition (legume- and vegetable-forward, EVOO as fat, fish weekly, low red meat, low processed) and substitutes local equivalents (oats, barley, lentils, sardines, walnuts, regional vegetables).

contraindications

Genuine medical contraindications are narrow. Advanced chronic kidney disease (CKD stages 4–5) may require restriction of potassium-rich vegetables and legumes — but this is dietitian-supervised, not a contraindication to plant-forward eating per se. Severe nut allergy precludes the nut-supplemented variant; the EVOO and base patterns remain. Olive or olive-oil allergy is rare but real. Pregnant women should observe standard fish-mercury guidance (≤2–3 servings/week of low-mercury fish; avoid high-mercury species). Wine is contraindicated in pregnancy, alcohol use disorder, and several medications (warfarin, certain antidepressants, metronidazole) — the recommendation should always omit wine from any general protocol description.

misconceptions

Several common misreadings persist. (1) "Mediterranean = pasta and bread." The traditional pattern was legume-, vegetable-, and fish-dominant; pasta and bread were portions of larger meals, not centerpieces. Americanized "Mediterranean" menus (pasta primavera, garlic bread, cheese-heavy pizza) inherit the marketing without the composition. (2) "Olive oil is too high in calories." PREDIMED's EVOO arm consumed ~50 g/day of supplemented oil on top of background use and showed favorable weight and waist outcomes Estruch et al. 2019. Higher dietary fat displaces refined carbohydrate; satiety is greater per calorie. (3) "Low-fat is the gold standard, Mediterranean is a fad." The current evidence base puts Mediterranean ahead of low-fat in head-to-head RCTs for cardiovascular outcomes (PREDIMED, CORDIOPREV, Lyon all used a low-fat or "prudent" comparator). (4) "The wine component is essential." No trial isolated wine's contribution; the wine-free PREDIMED non-Spanish replications and analyses show the effect holds when wine is removed. (5) "It's just generic healthy eating." The specific composition (EVOO as primary fat, legumes weekly, fish weekly, polyphenol load, low ultra-processed) is more constrained and more evidenced than the platonic "balanced diet" of dietary guidance. (6) "Refined olive oil is the same." Polyphenol content drops 5–10× from extra-virgin to refined oil. Oleocanthal's anti-inflammatory activity is an EVOO-specific property Beauchamp et al. 2005. The grade matters.

audience

Applies broadly to all adults. Effect strongest where baseline diet is poor (Western processed-food-heavy) and where cardiometabolic risk is elevated (older adults, T2D, hypertension, dyslipidemia). Younger healthy adults still benefit on long-term risk trajectories but the absolute risk reduction over a 5-year window is smaller. Women: PREDIMED breast-cancer signal and the recent Nurses' Health long-follow-up data make the case for women particularly strong on cancer and long-mortality endpoints Toledo et al. 2015 Ghosn et al. 2024. People with depression have RCT-grade reason to consider it as a behavioral adjunct, not a replacement, to standard treatment Jacka et al. 2017.

alternatives

DASH diet (sodium-restricted, fruit/vegetable/low-fat-dairy/whole-grain emphasis) is the closest comparator; head-to-head trials are sparse but cohort data place DASH and Mediterranean at similar mortality reduction. DASH is sodium-specific; Mediterranean is fat-composition-specific. The MIND diet is an explicit hybrid optimised for cognition. Nordic diet (rapeseed/canola oil, root vegetables, berries, oily fish) shows comparable cardiometabolic profile in Scandinavian cohorts. Low-carbohydrate and ketogenic patterns produce faster weight loss and glycemic gains at 6 months but lose the differential by 24 months; cardiovascular mortality evidence is weaker. Whole-food plant-based (Ornish, Esselstyn) shows the strongest LDL drops but adherence is lower and the evidence base is smaller. Mediterranean wins on the breadth and quality of trial evidence and on long-term adherability.

failure-modes

The most common practical failure is composition drift: keeping the marketing label while eating refined pasta, white bread, cheese-heavy pizza, and minimal vegetables. Adherence-score data from US cohorts shows self-reported "Mediterranean diet" frequently corresponds to mid-range adherence at best — the protective effect is concentrated in the highest-adherence tertile or quintile. Second is EVOO substitution: refined olive oil or "light" olive oil has the fat composition but only a fraction of the polyphenols; the anti-inflammatory mechanism is degraded. Third is fish replaced by deep-fried or breaded fish, which restores the inflammatory load. Fourth is processed-meat creep — bacon-laced salads, charcuterie boards, deli meats — which cancels much of the red-meat reduction the pattern depends on. Fifth is under-fishing: the omega-3 contribution from one fish meal per week is too small; the pattern wants two or more. Sixth is under-leguming: lentils, chickpeas, white beans, fava beans are the protein anchor that displaces red meat and provides the fiber substrate; many adherents skip them.

practicalities

Cost: a Mediterranean-pattern grocery basket adds roughly $5–$15 per person per week over a baseline ultra-processed cart in US 2020s pricing, driven mostly by EVOO (~$15–$25/L for usable quality), fish (~$8–$15/serving), and nuts (~$10–$15/lb). Legumes and seasonal vegetables are cheap; canned legumes, frozen vegetables, and canned sardines or mackerel are budget-equivalent options that preserve the composition. Effort: requires home cooking most days; one-pot legume dishes and traybake vegetables are the lowest-friction defaults. Restaurants: Mediterranean and Lebanese restaurants natively comply; Italian and Spanish restaurants comply if pasta portions are moderate and protein anchors are fish, legumes, or chicken. Travel and social eating are the main friction points but the pattern is permissive enough to absorb occasional deviations without losing the trajectory.

stakes

Counterfactual is the typical Western dietary trajectory: progressive insulin resistance, gradual visceral fat accumulation, BP creep, LDL drift, hs-CRP elevation, declining microbiome diversity, and the resulting absolute risk of MI, stroke, T2D, and dementia accumulating across decades. Sofi pooled HR of 0.92 for all-cause mortality per 2-point adherence step Sofi et al. 2014 implies meaningful life-expectancy differentials at the population level; Trichopoulou's Greek EPIC analysis estimated ~25% reduction in CV mortality over decade follow-up at top-quintile adherence Trichopoulou et al. 2003. At secondary-prevention scale, CORDIOPREV's ~26% reduction in major CV events over 7 years translates directly to events avoided in the kind of patient who has already had one event Delgado-Lista et al. 2022. Untreated baseline cardiovascular drift is silent until it isn't; the stakes are the events that don't announce themselves before they happen.

payoff

Felt-experience effects within weeks to months: postprandial energy stabilises (less afternoon crash); digestion normalises (fiber → bulkier, more regular stools, less reflux from displaced ultra-processed evening eating); BP measurably lower at 4–8 weeks; lipid panel measurably better at 8–12 weeks; mood lift documented in SMILES at 12 weeks Jacka et al. 2017. Beauty effects via polyphenol load and omega-3 (skin elasticity, reduced erythema, slower photo-aging) take months but are visible over a year. Cognitive effects (less brain-fog, better verbal fluency) take longer to register felt-experientially but the 4–6 year cognitive substudies show measurable gains Martínez-Lapiscina et al. 2013. Mortality and dementia payoffs play out over decades but are the largest in absolute terms.

history

Ancel Keys's Seven Countries Study (1950s onward) documented the low CHD rates of Crete and southern Italy and proposed the cuisine as the explanation. The 1990s Lyon Diet Heart Study moved the pattern from epidemiology to randomized trial. The PREDIMED trial (2003–2011, published 2013, retracted-republished 2018) was the definitive primary-prevention RCT. UNESCO inscribed the Mediterranean diet on the Representative List of the Intangible Cultural Heritage of Humanity in 2013, recognizing it as a cultural practice rather than only a dietary intervention.

Credibility range

Optimist case

This is the most-evidenced dietary pattern in the history of nutrition science. It carries multiple primary- and secondary-prevention RCTs (PREDIMED, Lyon, CORDIOPREV) converging on ~25–30% relative reduction in major CV events; an RCT-grade signal in depression (SMILES) of effect size comparable to an SSRI; cancer signals in PREDIMED's prespecified breast-cancer substudy; a diabetes-prevention RCT; cognitive RCT substudies; consistent observational mortality signal in cohorts totaling millions of person-years; mechanistic plausibility through polyphenols, MUFAs, omega-3s, fiber, and microbiome shift; and Class I guideline endorsement from ACC/AHA. The pattern is composition-defined and palatable, with cuisine traditions to learn from rather than reinventing; long-term adherence outpaces low-carb and low-fat in head-to-head trials. The pattern is weight-favorable at high fat intake without caloric restriction. No other dietary intervention has this combination of evidence quality, effect size, and adherability.

Skeptic case

PREDIMED 2013 was retracted in 2018 over randomization deviations; the republished analysis used multilevel modeling to account for site-level cluster randomization, and while the conclusions held, the original simple-randomization claim did not. The Spanish olive oil producers' association co-funded the EVOO supply, an industry tie. The control arm in PREDIMED received "advice on a low-fat diet" but in practice didn't reduce fat much — possibly inflating the contrast. The Lyon Diet Heart Study was small (n=605) and the canola-margarine intervention is not exactly Mediterranean as eaten. Cohort evidence is observational, subject to healthy-user bias (Mediterranean adherents in Northern Europe and the US tend to be more educated, wealthier, more active, less likely to smoke). The "Mediterranean diet" is heterogeneously defined across studies, with multiple scoring systems and different cutoffs; null components have been added and removed at researcher discretion. The mortality effect of any single component (olive oil, fish, legumes, vegetables) is hard to isolate from the pattern; what's robust is the pattern, not the bioactives. Outside Mediterranean cultures, adherence drifts toward an Americanized facsimile that no longer carries the protection. Low-carbohydrate and ketogenic advocates argue Mediterranean's permissiveness on whole grains and fruit is a defect for already-insulin-resistant populations. The effect is real but partly culture-bundled — community eating, mealtime structure, light physical activity, and lower stress likely contribute alongside the food composition.

Author's call

Evidence is at the top of the catalogue's nutrition tier. The PREDIMED retraction is a procedural fault that survived re-analysis intact and does not undermine the directionality; the industry tie is real and modest. Independent replication in CORDIOPREV (no Spanish olive oil ties) under secondary prevention, plus the Lyon evidence under a different geography and design, plus consistent direction across millions of person-years of cohort data, plus mechanism plausibility through multiple converging pathways, plus AHA Class I endorsement — this clears the highest evidence bar the catalogue uses. Score evidence at 5, controversy at 2 (real procedural pushback on PREDIMED, real low-carb-camp disagreement on grain permissiveness, but the field is broadly aligned). The pattern is dominant on longevity, substantial on health, mood, and beauty cumulative, meaningful on cognition and energy, modest on direct beauty and sleep.

Stakeholder and incentive map

• Commercial supporters: Spanish/Italian/Greek olive oil producers, nut growers (California almond and walnut industries), seafood industry. Olive oil producers' association co-funded PREDIMED supplies; this is a real conflict though not large enough to invalidate the trial.
• Professional supporters: ACC/AHA, ESC, ADA, USDA Dietary Guidelines committee, registered dietitian profession. Class I guideline endorsement.
• Cultural carriers: Mediterranean countries' tourism boards, UNESCO heritage designation, cooking-book industry.
• Counter-camps: Low-carbohydrate and ketogenic advocates (Taubes, Attia for nuance, some functional-medicine practitioners) argue grain permissiveness is wrong; carnivore advocates reject the pattern. Industrial food, processed-meat, refined-grain, and sugar industries lose share. Statin manufacturers don't lose share (Mediterranean is endorsed adjunct, not replacement). Plant-based-only (Ornish, Greger) advocates think Mediterranean is too lax on animal foods.

Population variability

• Baseline diet: Effect largest where baseline is worst (ultra-processed-heavy). A Greek 70-year-old already eating traditional has limited margin to gain.
• Cardiometabolic risk status: PREDIMED and CORDIOPREV recruited elevated-risk populations; effect sizes there may overestimate what a low-risk 30-year-old can expect on a 5-year window. Long-term trajectory effect remains.
• Sex: Women carry the breast-cancer signal; both sexes show CV and mortality benefit. Recent women-specific 25-year mortality data is robust Ghosn et al. 2024.
• Age: Older adults show the largest absolute CV event reductions; younger adults gain on the cumulative trajectory.
• Genetics: APOE-ε4 carriers show particularly strong cognitive benefit from MIND/Mediterranean adherence in some analyses; this is exploratory but biologically plausible (LDL/inflammation pathway).
• Mental health: SMILES recruited moderate-to-severe MDD patients with poor baseline diet; effect may not transfer to mild depression or to patients already eating well.
• Cultural adherence: Native-Mediterranean populations sustain adherence better than US/UK adopters; the effect estimates from PREDIMED may overstate what a Northern European or American can sustain.

Knowledge gaps

• Which components are load-bearing? No trial isolates EVOO from polyphenol load from fiber from omega-3. Component-substitution trials (e.g., refined vs extra-virgin olive oil head-to-head over years) are sparse.
• Optimal dose of EVOO. PREDIMED used 50 g/day of supplemented oil; lower doses may suffice but haven't been formally tested at scale.
• Wine question. No randomized trial has isolated wine; the evidence is observational and confounded by socioeconomic status, dose, and pattern of intake. Current consensus (2023 WHO statement, recent Lancet analyses) is that no level of alcohol is health-promoting at the population level; the Mediterranean diet recommendation now typically de-emphasizes or omits wine.
• Generalisation to Asian, African, and indigenous-American populations is under-tested. Substitution patterns (e.g., rapeseed for olive oil, soy for legumes, regional fish species) may preserve the effect but haven't been formally proven.
• Mechanism: gut microbiome's mediating role is biologically plausible but the causal chain from MedDiet → microbiome shift → clinical endpoint is not closed.
• Time-to-effect for individual endpoints is poorly characterized. We know CV events accrue over years; we don't have clean dose-response curves for BP, lipids, hs-CRP, or mood over weeks.
• What evidence would change the call: a large, well-controlled RCT showing Mediterranean fails head-to-head against a comparable plant-forward low-fat or low-carb pattern on hard endpoints; demonstration that the effect is wholly explained by replacing ultra-processed foods rather than by the specific composition.

Top-of-catalogue scoring (~74 overall). Treated as obligatory-dream-narrative tier; dek, opening paragraph, payoff, and tagline all written from the dream narrative with the marketing-words ban lifted in proportion.

Topic brief named cardiovascular risk, blood lipids, blood pressure, glycemic control, cognition, mood, and longevity. All seven covered: mechanism + evidence sections handle the CV/lipids/BP/glycemic block, mood gets its own coverage via SMILES/HELFIMED/Lassale, cognition via PREDIMED-NAVARRA and MIND, longevity via Sofi/Dinu/Ghosn/Trichopoulou. Body composition included as a sub-thread under payoff and misconceptions because PREDIMED's weight outcomes are a well-evidenced consequence and the EVOO-is-too-many-calories misconception is one of the most common reader objections.

Hard scoping calls:

• Wine omitted from the protocol section. The traditional PREDIMED 14-item adherence checklist includes ≥7 servings/week red wine. The current alcohol-research consensus (WHO 2023, recent Lancet analyses) is that no level of alcohol is health-promoting; no RCT has isolated wine's contribution. Including it in a "do this" protocol would be a net editorial harm. The omission is named explicitly in protocol and misconceptions so the reader who comes from the traditional checklist understands why this entry diverges.
• Cancer treated as a sub-claim under evidence rather than its own dimension/section. The PREDIMED breast cancer substudy is real but underpowered (62 events). Schwingshackl's meta-analysis on overall cancer mortality is convincing in direction but modest in magnitude. The cancer signal contributes to the longevity score; it does not warrant its own section.
• Gut microbiome treated as mechanism, not its own dimension. Garcia-Mantrane and broader microbiome literature is plausible mechanism, but the causal chain from MedDiet → microbiome shift → clinical endpoint is not closed. Folded into mechanism, not surfaced as a standalone consequence.

Rating difficulties:

• Effort burden 3 vs 4. Borderline. The pattern is permissive — no caloric restriction, no banned macronutrient, social-flexible — but the cooking and learning curve are real. Landed at 3 (substantial, comparable to other major sustained dietary changes) rather than 4 (the punishing-restriction tier reserved for, say, strict carnivore or strict whole-food plant-based).
• Sleep score 2 vs 0. No dedicated sleep RCT. Observational adherence-vs-sleep-quality data and mechanism (reduced inflammation, less reflux, fewer postprandial spikes) support a small effect. Chose 2 over 0 to be honest about real-but-modest ancillary effects rather than zero-out a dimension where the evidence is directional but thin. Pitch makes the smallness explicit.
• Controversy 2 vs 3. PREDIMED retraction-republication, industry funding, and the low-carb camp's pushback are all real. Landed at 2 because mainstream cardiology, nutrition, and guideline bodies are broadly aligned; the disagreement is at the margins, not foundational.

Future-link candidates (named in out-of-scope but most do not yet exist as entries):

• extra-virgin olive oil — standalone, the polyphenol/grade-question deep dive
• legumes — class entry covering lentils/chickpeas/beans across longevity diets
• fish and omega-3 fatty acids — EPA/DHA, food vs supplementation
• fibre — as a target in its own right
• ultra-processed food — the inverse pattern, probably the larger isolated lever
• DASH diet — the sodium-restricted comparator
• MIND diet — cognition-optimised hybrid (could be its own entry or merged here)
• cardiovascular risk panel — LDL, ApoB, hs-CRP, fasting glucose, HbA1c
• alcohol — the omitted wine line deserves its own honest treatment

Separate-entry candidates: MIND diet is borderline — it could live as a sub-section here or as its own entry. Recommend its own entry once cognition-focused content expands.

Citation note: PREDIMED is cited via the 2018 republished paper (Estruch et al. 2018, NEJM), not the retracted 2013 original. The retraction is named in the article body where it matters for credibility.